Largest companies by market cap
market cap
| Company | Market cap | Sector | Industry | Country | Exchange |
|---|---|---|---|---|---|
| 301 | $24.19M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 302 | $23.58M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 303 | $23.31M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 304 | $23.25M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 305 | $19.76M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 306 | $19.75M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 307 | $19.58M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 308 | $19.56M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 309 | $18.76M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 310 | $18.38M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 311 | $17.74M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 312 | $17.68M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 313 | $17.30M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 314 | $17.23M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 315 | $17.06M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 316 | $16.04M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 317 | $15.41M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 318 | $15.07M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 319 | $14.25M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 320 | $13.93M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 321 | $13.52M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 322 | $13.18M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 323 | $13.17M | Healthcare | Pharmaceuticals | United States | NYSE |
| 324 | $13.16M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 325 | $12.31M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 326 | $12.17M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 327 | $12.11M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 328 | $11.92M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 329 | $11.73M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 330 | $11.47M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 331 | $11.08M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 332 | $11.07M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 333 | $11.00M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 334 | $10.61M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 335 | $9.94M | Healthcare | Pharmaceuticals | United States | NYSE |
| 336 | $9.64M | Healthcare | Pharmaceuticals | United States | NYSE |
| 337 | $9.60M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 338 | $9.47M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 339 | $9.06M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 340 | $8.90M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 341 | $8.37M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 342 | $8.35M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 343 | $8.21M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 344 | $8.08M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 345 | $7.80M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 346 | $7.74M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 347 | $7.47M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 348 | $7.47M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 349 | $7.06M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 350 | $6.67M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 351 | $5.81M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 352 | $5.66M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 353 | $5.46M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 354 | $5.41M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 355 | $5.14M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 356 | $4.59M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 357 | $4.50M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 358 | $4.40M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 359 | $4.38M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 360 | $4.00M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 361 | $3.44M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 362 | $3.36M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 363 | $3.34M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 364 | $3.17M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 365 | $2.73M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 366 | $2.62M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 367 | $2.59M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 368 | $2.55M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 369 | $2.30M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 370 | $2.13M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 371 | $2.13M | Healthcare | Pharmaceuticals | United States | NYSE |
| 372 | $1.93M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 373 | $1.51M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 374 | $0.06M | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 375 | — | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 376 | — | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 377 | — | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 378 | — | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 379 | — | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 380 | — | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 381 | — | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 382 | — | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 383 | — | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 384 | — | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 385 | — | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 386 | — | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 387 | — | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 388 | — | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 389 | — | Healthcare | Pharmaceuticals | United States | NYSE |
| 390 | — | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 391 | — | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 392 | — | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 393 | — | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 394 | — | Healthcare | Pharmaceuticals | United States | NYSE |
| 395 | — | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 396 | — | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 397 | — | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 398 | — | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 399 | — | Healthcare | Pharmaceuticals | United States | Nasdaq |
| 400 | — | Healthcare | Pharmaceuticals | United States | Nasdaq |
U.S.-exchange common stocks; ADRs and funds excluded. 409 companies. Market capitalization in USD.